Bradford’s regulatory framework for the beauty and body piercing industry has its roots in 1982, when the council enacted by-laws covering ear piercing, tattooing, acupuncture, and electrolysis. Those rules were designed to enforce hygiene standards and reduce the transmission of infections and blood-borne diseases — legitimate public health objectives that have not diminished with time.
Four decades on, however, the industry has changed beyond recognition. Cosmetic body piercing and semi-permanent skin colouring have grown into mainstream treatments, yet neither falls within the scope of the existing legislation, leaving a conspicuous regulatory gap that the council is now seeking to close.
Most businesses operating in Bradford currently register with the council on a voluntary basis, a sign that the industry is not inherently resistant to oversight. At a meeting of the regulatory and appeals committee on Wednesday, councillors discussed converting that voluntary arrangement into a compulsory registration requirement, a step that would give the council meaningful enforcement powers rather than relying on goodwill.
Senior environmental officer Jane Bradbury set out the case plainly. “There has been a massive rise in beauty treatments,” she told members, “and we have to make sure we have adequate by-laws in place to cover these businesses.” The argument is straightforward: where health risks exist, regulatory authority should follow.
Councillors also raised the question of anti-wrinkle injections and dermal fillers, two procedures that have surged in popularity and carry their own risk profile. Officers confirmed that current legislation does not permit local authorities to regulate those treatments, though a national licensing scheme is understood to be in development.
The urgency of that national scheme was underscored earlier this year, when the UK Health Security Agency reported that a small number of patients had presented to NHS services around Leeds with signs of botulism following aesthetic treatments involving botulinum toxin. Botulism, caused by toxins produced by Clostridium botulinum bacteria, is rare but serious, and the cluster illustrated precisely what can go wrong when high-risk procedures operate outside any formal oversight structure.
If the committee approves the proposed changes, the council’s next step will be to apply to central government for new by-laws. That process is not swift, but it is the correct constitutional route — local authorities cannot simply legislate themselves new powers, and Bradford is rightly working within that framework rather than around it.
The episode illustrates a wider pattern: regulation drafted for one era struggles to keep pace with markets that innovate continuously. The beauty industry’s expansion into semi-permanent and injectable treatments has outrun the statutory tools available to councils, and the gap between what is popular and what is regulated has become difficult to ignore.

